Sara Torres‐Esquius

Large scale multifactorial likelihood quantitative analysis of <i>BRCA1</i> and <i>BRCA2</i> variants: An ENIGMA resource to support clinical variant classification

Michael T. Parsons, Emma Tudini, Hongyan Li et al. · Human Mutation · 2019 · 148 citations · Full text

Genetics, Genetic Epidemiology, Pathology +25

Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings

Sandra Bonache, I. Esteban, Alejandro Moles‐Fernández et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 65 citations · Full text

Breast Oncology, Cancer Risk, Multigene Panel +8

Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction

Neda Stjepanovic, Guillermo Villacampa, Kevin T. Nead et al. · European Journal of Cancer · 2020 · 22 citations · Full text

Surgical Oncology, Epidemiology, Cancer Epidemiology +14

Prevalence of Homologous Recombination Deficiency Among Patients With Germline <i>RAD51C/D</i> Breast or Ovarian Cancer

Sara Torres‐Esquius, Alba Llop‐Guevara, Sara Gutiérrez‐Enríquez et al. · JAMA Network Open · 2024 · 17 citations · Full text

BARD1 Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort

Paula Rofes, Jesús Del Valle, Sara Torres‐Esquius et al. · Genes · 2021 · 16 citations · Full text